The projects look interesting and the market is still strong, so they should get their money. However, they have been abysmal over the last 4 years. Maybe a clean-up of the board would help.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
